Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John A Thompson

Showing results (81-90 of 290) with videos related to

Pageof 29
Sort By:
Brain Stimulation|April 3, 2025
Aperiodic activity as a biomarker of seizures and neuromodulationDavid Satzer, Lesley C Kaye, Steven G Ojemann, et al.
Carcinogenesis|February 14, 2006
Fractionation of grape seed extract and identification of gallic acid as one of the major active constituents causing growth inhibition and apoptotic death of DU145 human prostate carcinoma cellsRavikanth Veluri, Rana P Singh, Zhengjie Liu, et al.
Clinical Genitourinary Cancer|October 10, 2009
Safety and efficacy of PF-3512676 for the treatment of stage IV renal cell carcinoma: an open-label, multicenter phase I/II studyJohn A Thompson, Timothy Kuzel, Beverly J Drucker, et al.
Carcinogenesis|March 3, 2007
Fractionation of high molecular weight tannins in grape seed extract and identification of procyanidin B2-3,3'-di-O-gallate as a major active constituent causing growth inhibition and apoptotic death of DU145 human prostate carcinoma cellsChapla Agarwal, Ravikanth Veluri, Manjinder Kaur, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 12, 2020
Discrete changes in brain volume after deep brain stimulation in patients with Parkinson's diseaseDrew S Kern, Daniel Uy, Remy Rhoades, et al.
Sleep|January 11, 2025
Diurnal fluctuations of subthalamic nucleus local field potentials follow naturalistic sleep-wake behavior in Parkinson's diseaseAlexander J Baumgartner, Lisa Hirt, Amy W Amara, et al.
Stereotactic and Functional Neurosurgery|July 15, 2024
Neurophysiologic Characteristics of the Anterior Nucleus of the Thalamus during Deep Brain Stimulation Surgery for EpilepsyMegan V Ryan, David Satzer, Steven G Ojemann, et al.
Plos One|March 10, 2009
Fludarabine modulates immune response and extends in vivo survival of adoptively transferred CD8 T cells in patients with metastatic melanomaHerschel Wallen, John A Thompson, J Zachary Reilly, et al.
Frontiers in Psychiatry|April 19, 2021
Deep Brain Stimulation for Obsessive-Compulsive Disorder: Real World Experience Post-FDA-Humanitarian Use Device ApprovalLora Kahn, Brianne Sutton, Helena R Winston, et al.
Stereotactic and Functional Neurosurgery|April 6, 2025
Comparison of Deep Brain Stimulation and Responsive Neurostimulation Wound Complication Rates and Risk Factors: A Single-Center Retrospective StudyEric Bayman, Chiagoziem Anigbogu, Ashkaun Razmara, et al.
Pageof 29

Showing results (81-90 of 290) with videos related to

Sort By:
Pageof 29
Brain Stimulation|April 3, 2025
Aperiodic activity as a biomarker of seizures and neuromodulationDavid Satzer, Lesley C Kaye, Steven G Ojemann, et al.
Carcinogenesis|February 14, 2006
Fractionation of grape seed extract and identification of gallic acid as one of the major active constituents causing growth inhibition and apoptotic death of DU145 human prostate carcinoma cellsRavikanth Veluri, Rana P Singh, Zhengjie Liu, et al.
Clinical Genitourinary Cancer|October 10, 2009
Safety and efficacy of PF-3512676 for the treatment of stage IV renal cell carcinoma: an open-label, multicenter phase I/II studyJohn A Thompson, Timothy Kuzel, Beverly J Drucker, et al.
Carcinogenesis|March 3, 2007
Fractionation of high molecular weight tannins in grape seed extract and identification of procyanidin B2-3,3'-di-O-gallate as a major active constituent causing growth inhibition and apoptotic death of DU145 human prostate carcinoma cellsChapla Agarwal, Ravikanth Veluri, Manjinder Kaur, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 12, 2020
Discrete changes in brain volume after deep brain stimulation in patients with Parkinson's diseaseDrew S Kern, Daniel Uy, Remy Rhoades, et al.
Sleep|January 11, 2025
Diurnal fluctuations of subthalamic nucleus local field potentials follow naturalistic sleep-wake behavior in Parkinson's diseaseAlexander J Baumgartner, Lisa Hirt, Amy W Amara, et al.
Stereotactic and Functional Neurosurgery|July 15, 2024
Neurophysiologic Characteristics of the Anterior Nucleus of the Thalamus during Deep Brain Stimulation Surgery for EpilepsyMegan V Ryan, David Satzer, Steven G Ojemann, et al.
Plos One|March 10, 2009
Fludarabine modulates immune response and extends in vivo survival of adoptively transferred CD8 T cells in patients with metastatic melanomaHerschel Wallen, John A Thompson, J Zachary Reilly, et al.
Frontiers in Psychiatry|April 19, 2021
Deep Brain Stimulation for Obsessive-Compulsive Disorder: Real World Experience Post-FDA-Humanitarian Use Device ApprovalLora Kahn, Brianne Sutton, Helena R Winston, et al.
Stereotactic and Functional Neurosurgery|April 6, 2025
Comparison of Deep Brain Stimulation and Responsive Neurostimulation Wound Complication Rates and Risk Factors: A Single-Center Retrospective StudyEric Bayman, Chiagoziem Anigbogu, Ashkaun Razmara, et al.
Pageof 29